Zdrowie i gospodarka · 23/10/2013
FDA Clears INTAL Inhalation Capsule for Approval
The FDA has determined that INTAL (cromolyn sodium) Inhalation Capsule, 20 mg, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of cromolyn sodium inhalation capsules.
Source: Federal Register — Food and Drug AdministrationOpen original release →